Get reimbursed for COVID-19 testing and treatment of uninsured individuals.     Learn more »

AIDS Drug Assistance Program (ADAP) Emergency Relief Funds (ERF)

Announcement Number:
HRSA-22-035

Bureau/Office:
HIV/AIDS Bureau

Date(s) to Apply:
07/26/2021 to 10/25/2021

Estimated Award Date:
04/01/2022


What is the program?

This notice announces the opportunity to apply for funding under the Ryan White HIV/AIDS Program (RWHAP) Part B AIDS Drug Assistance Program (ADAP) Emergency Relief Funds (ERF). The Health Resources and Services Administration (HRSA), HIV/AIDS Bureau (HAB), Division of State HIV/AIDS Programs (DSHAP) administers this program.
ADAP ERF awards are intended for states/territories that demonstrate the need for additional resources to prevent, reduce, or eliminate ADAP waiting lists, including through cost-containment measures (for example, the provision of health care coverage assistance). HRSA will base ADAP ERF awards upon your ability to successfully demonstrate need for additional funding. An external objective review committee (ORC) will evaluate this need based on criteria published in this notice of funding opportunity (NOFO), with priority given to addressing existing waiting lists.
HRSA first funded the ERF initiative in August 2010, when numerous states/territories were experiencing ADAP waiting lists. At the time of this NOFO publication, there are no ADAP waiting lists. States/territories that establish a waiting list after the publication of this NOFO must report the waiting list to HRSA immediately and use funding awarded under this NOFO to remove clients from the waiting list. Previously, eligibility for this funding was limited to states/territories that had historically imposed waiting lists. HRSA continues to anticipate an increase in potential clients in need of ADAP services due to loss of income and/or loss of health care coverage among people with HIV resulting from the economic downturn within states/territories. States/territories may use ERF funds to address current or projected increases in treatment needs aligned with ending the HIV epidemic in the U.S. or other unanticipated increases in the number of clients in their ADAP.


Are you eligible?

All 50 States, the District of Columbia, the Commonwealth of Puerto Rico, the U.S. Virgin Islands, Guam, American Samoa, the Commonwealth of the Northern Mariana Islands, the Republic of Palau, the Federated States of Micronesia, and the Republic of the Marshall Islands are eligible to apply for funding if they meet the following requirements:
Eligible applicants are limited to RWHAP Part B states/territories that:
• have reported to HRSA an existing ADAP waiting list,
• have used the ADAP ERF to prevent, reduce, or eliminate an ADAP waiting list between January 2011 and July 2021,
• need additional funding for a projected increase in treatment needs aligned with ending the HIV epidemic in the U.S.,
or
• need additional funding for other unanticipated increases in the number of clients in the program due to new diagnosis, re-engagement in care, loss of income, and/or loss of health care coverage.
States/territories that did not: 1. report a new ADAP waiting list to HRSA, or 2. use the ADAP ERF to prevent, reduce, or eliminate an ADAP waiting list between January 2011 and July 2021, or 3. that do not have a projected increase in treatment needs aligned with ending the HIV epidemic in the U.S., or other unanticipated increases in the number of clients in the program due to new diagnosis, re-engagement in care, loss of income, and/or loss of health care coverage, are not eligible to apply.

Contact Us

Susan Robilotto, D.O.

SRobilotto@hrsa.gov

Phone: (301) 443-6554

Track Your Application

Use our track application tool